Showing 1 - 20 results of 20 for search 'James L Gulley', query time: 0.05s Refine Results
  1. 1
    Developing immunotherapy strategies in the treatment of prostate cancer

    Developing immunotherapy strategies in the treatment of prostate cancer by James L. Gulley, Ravi A. Madan

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

    Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management by Renee N Donahue, Jeffrey Schlom, James L Gulley, Lisa Cordes, Jennifer L Marté, Nicole J Toney

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development

    SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development by James L Gulley, Leisha A Emens, Patrick Hwu, Carlo B Bifulco, Pamela S Ohashi, Christine Moussion, David Feltquate

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Strategies for improving the management of immune-related adverse events

    Strategies for improving the management of immune-related adverse events by James L Gulley, Patrick Hwu, Gennaro Ciliberto, Aung Naing, Funda Meric-Bernstam, Michael B Atkins, Joud Hajjar

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival by James L Gulley, Sandra P D'Angelo, Marcis Bajars, Andrea B Apolo, Juliane Manitz, S Peter Eggleton, Oliver Bohnsack

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines

    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines by Renee N Donahue, Jeffrey Schlom, James L Gulley, James W Hodge, Claudia Palena, Duane H Hamilton, Sofia R Gameiro

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody

    Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody by Italia Grenga, Caroline Jochems, Massimo Fantini, James L. Gulley, Christopher R. Heery, Renee N. Donahue, Ravi A. Madan, Jeffrey Schlom, Lauren M. Lepone

    Published 2017-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma

    Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma by Patrick Hallaert, John W. Roman, Mairead Baker, Natasha T. Hill, Jennifer L. Marte, James L. Gulley, Nicholas Logemann, Courtney W. Hudgens, Alexandre Reuben, Isaac Brownell

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

    Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific... by Renee N Donahue, Jeffrey Schlom, James L Gulley, Claudia Palena, Duane H Hamilton, Masafumi Iida, Maria del Mar Maldonado, Maria Gracia-Hernandez, Loc Huu Le

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants

    Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants by James L Gulley, Ling Zhang, Christian S Hinrichs, John S Davies, Andrew Sinkoe, Wiem Lassoued, Farrah Karimipour, Philip Homan, Daniel Burnett, Scott M Norberg, Alex Kuznetsov, Margaret Cam, Ping Xue

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy

    Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy by Jeffrey Schlom, James L Gulley, Caroline Jochems, Sofia R Gameiro, Wiem Lassoued, Daniel Burnett, Lisa K Poppe, Nicholas Roller, Miriam Marlene Medina-Enríquez, Katherine E Lothstein, Asma S Khelifa, Masaya Miyamoto

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma

    Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma by Bryce Hambach, Anhelina Bilokon, John Lee, L. Noelle Allemang, Jennifer Chisholm, Chris K. Zalewski, Julie Christensen, Carmen C. Brewer, James L. Gulley, Clint T. Allen, Lisa L. Cunningham, Katharine A. Fernandez

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation

    Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation by Catherine J. Wang, Jennifer Strong, Margaret E. Gatti-Mays, Wiem Lassoued, Sam Sater, Julius Strauss, Jason M. Redman, Jason M. Redman, Jeffrey Schlom, James L. Gulley, Isaac Brownell, Isaac Brownell

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

    Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer by Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Elizabeth Lamping, Osama Rahma, Houssein Abdul Sater, Jennifer L Marté, Beatriz Walter-Rodriguez, Yulia Vugmeyster, Yo-Ting Tsai, Shania Bailey, Wiem Lassoued, Richy Agajanian, Andrew Weisman, Rena Ito, Masashi Sato, Andreas Machl

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study

    Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study by James L Gulley, Jaafar Bennouna, Guy Jerusalem, Janice Mehnert, Matthew Taylor, Karen Kelly, David Spigel, Marcis Bajars, Claire F Verschraegen, Edward F McClay, Nicholas Iannotti, Charles H Redfern, Franklin L Chen, John C Morris, Ding Wang, Hans Juergen Grote, Dongli Zhou, Neru Munshi

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Immunotherapy biomarkers 2016: overcoming the barriers

    Immunotherapy biomarkers 2016: overcoming the barriers by Jeffrey Schlom, Lisa H Butterfield, Jianda Yuan, Alessandra Cesano, Janet Siebert, Barbara Seliger, Jay A. Berzofsky, James L. Gulley, Holden Maecker, Bernard A. Fox, Marcus O. Butler, Cristina Maccalli, Sacha Gnjatic, Vaios Karanikas, Ilan Kirsch, Sylvia Janetzki, Samir N. Khleif, Magdalena Thurin, Peter P. Lee, Shyam Kalavar, David F. Stroncek

    Published 2017-08-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer

    PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer by Charalampos S. Floudas, Meghali Goswami, Renee N. Donahue, Julius Strauss, Danielle M. Pastor, Jason M. Redman, Isaac Brownell, Evrim B. Turkbey, Seth M. Steinberg, Lisa M. Cordes, Jennifer L. Marté, Maheen H. Khan, Sheri McMahon, Elizabeth Lamping, Michell Manu, Manuk Manukyan, Douglas E. Brough, Amy Lankford, Caroline Jochems, Jeffrey Schlom, James L. Gulley

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer

    Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer by Colin Pritchard, Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Fatima Karzai, Amy Hankin, Jennifer L Marté, Ismail Baris Turkbey, Yo-Ting Tsai, Manuk Manukyan, Moniquea Williams, William Dahut, Shania Bailey, Wiem Lassoued, Michell Manu, Peter Pinto, Daniel Burnett, Elisabetta Xue, Kenneth D Canubas, Antonios Papanicolau-Sengo, Zhigang Kang, Sam Sater

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies by Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Caroline Jochems, Elizabeth Lamping, Julius Strauss, Marijo Bilusic, Fatima Karzai, Christian S Hinrichs, Edward McClay, Jennifer L Marté, Lisa M Cordes, Andrew Hill, Byoung Chul Cho, Sébastien Salas, Laureen S Ojalvo, P Alexander Rolfe, Margaret E Gatti-Mays, Jason M Redman, Houssein A Sater, Andrea Burmeister, Genevieve Jehl

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce

    Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce by Mario Sznol, Roberta Zappasodi, Margaret K. Callahan, Dung T. Le, Robert L. Ferris, James L. Gulley, Charles G. Drake, Ryan J. Sullivan, Elad Sharon, Hussein A. Tawbi, Harriet M. Kluger, Janis M. Taube, Shilpa Gupta, Suzanne L. Topalian, Edward Cha, Michael A. Postow, Vassiliki A. Papadimitrakopoulou, Maria L. Ascierto, Michaela Bowden, Helen X. Chen, David M. Feltquate, Rachel W. Humphrey, Theresa M. LaVallee, Vanessa M. Hubbard-Lucey, Eric H. Rubin

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: